funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Crunchbase, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline.
Figures are computed live from our source-verified story record
— see our methodology for how impact and
sentiment are derived.
What the coverage shows about Blood-Drawing Robots
funding is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Crunchbase, the most common co-covered peer. Source depth averages 2 original sources per story, versus 3.2 across the same-window beat baseline. At 6, the average consequence score sits below the same-window beat average of 6.3. Blood-Drawing Robots appears in 1 tracked Startup story from March 13, 2026.
Stories tracked
1
Sources per story
2
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 30 Startup stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Appears alongside
Other entities that clear the same relevance threshold in stories also covering Blood-Drawing Robots. Shared-story counts are live from our verified record — not editorial picks.
Venture capital is pivoting toward 'Hard Tech' and specialized infrastructure, with recent deals highlighting autonomous medical robots and distributed defense manufacturing. These investments signal a shift from general-purpose AI to solutions addressing critical labor shortages and sovereign supply chain resilience.
Blood-Drawing Robots is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source
link? Report a data issue.